Growth hormone response to clonidine in obese children

S K Singh1, J K Agrawal, M Rai

  • 1Department of Medicine, Banaras Hindu University, Varanasi.

Indian Pediatrics
|July 1, 1991
PubMed

Insights

Obese children show a subnormal growth hormone (GH) response to oral clonidine. Exercise and insulin-induced hypoglycemia tests also revealed diminished GH secretion in this group.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Physiology
  • Obesity Research

Background:

  • Obesity in children is a growing concern with potential impacts on endocrine function.
  • Growth hormone (GH) secretion plays a crucial role in childhood development.
  • Assessing GH secretion is important for identifying potential growth disorders.

Purpose of the Study:

  • To evaluate basal and stimulated serum growth hormone (GH) levels in normal-statured obese children.
  • To compare GH responses to exercise, insulin-induced hypoglycemia (IIH), and oral clonidine in obese children.
  • To determine if obesity affects GH secretion in response to various stimuli.

Main Methods:

  • Serum GH levels were measured in 20 normal-statured obese children (16 males, 4 females) with a body mass index (BMI) ≥ 25 kg/M2.
  • Stimulated GH release was assessed following exercise, IIH, and oral clonidine administration.
  • Basal GH levels were compared to those of non-obese children.

Main Results:

  • Basal serum GH levels in obese children were comparable to non-obese children.
  • Mean peak GH levels after exercise, IIH, and clonidine were 3.16, 2.15, and 3.15 ng/ml, respectively.
  • Positive GH responses (peak > 7 ng/ml) were observed in only 10% of children after exercise and clonidine, and in none after IIH.

Conclusions:

  • Obese children exhibit a subnormal GH response to oral clonidine.
  • The GH response to exercise and IIH may also be diminished in obese children.
  • These findings suggest potential alterations in GH regulation associated with childhood obesity.

Related Concept Videos

Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.